SCHEMBL8478563

SCHEMBL8478563

CCOC(=O)CCCC(CN)(CCOC1CCCCO1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SLC6A3 Q01959 5/20 0.36
OPRK1 P41145 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
OPRM1 P35372 1/20 0.33
TSHR P16473 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
P2RX3 P56373 1/20 0.31
BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543937 0.97 MEN1 (0.39) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL7761430 0.88 MEN1 (0.41) MEN1KMT2ASLC6A3KDM4EALDH1A1
SCHEMBL8125379 0.85 MEN1 (0.44) MEN1KMT2ASLC6A3ALDH1A1
SCHEMBL8485274 0.84 MEN1 (0.36) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL6543753 0.82 MEN1 (0.38) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL4630796 0.81 MEN1 (0.37) MEN1KMT2ASLC6A3SMN1; SMN2SLC6A4
SCHEMBL6952332 0.80 SLC6A3 (0.36) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL4631276 0.80 MEN1 (0.40) MEN1KMT2ASLC6A3P2RX3
SCHEMBL8484373 0.79 MEN1 (0.38) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL6947257 0.77 SLC6A3 (0.37) MEN1KMT2ASLC6A3OPRK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5859029-A TREATING SUBSTANCE P-DEPENDENT PATHOLOGICAL CONDITIONS SANOFI (FR) 1999-01-12 US disclosed
US-5656639-A POSSESS STRONG AFFINITY FOR NK1 RECEPTORS; USEFUL IN TREATMENT OF SUBSTANCE P-DEPENDENT PATHOLOGICAL CONDITIONS SANOFI (FR) 1997-08-12 US disclosed